Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6YKG

Structure-based exploration of selectivity for ATM inhibitors in Huntingtons disease

これはPDB形式変換不可エントリーです。
6YKG の概要
エントリーDOI10.2210/pdb6ykg/pdb
分子名称Phosphatidylinositol 3-kinase catalytic subunit type 3, 4-morpholin-4-yl-6-[(2~{R})-2-(phenylmethyl)pyrrolidin-1-yl]-1~{H}-pyridin-2-one (3 entities in total)
機能のキーワードhuntingtons disease; vps34, atm, lyase
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数1
化学式量合計72932.21
構造登録者
Van de Poel, A.,Leonard, P.M.,Lamers, M.B.A.C. (登録日: 2020-04-06, 公開日: 2021-04-14, 最終更新日: 2024-01-24)
主引用文献Van de Poel, A.,Toledo-Sherman, L.,Breccia, P.,Cachope, R.,Bate, J.R.,Angulo-Herrera, I.,Wishart, G.,Matthews, K.L.,Martin, S.L.,Peacock, M.,Barnard, A.,Cox, H.C.,Jones, G.,McAllister, G.,Vater, H.,Esmieu, W.,Clissold, C.,Lamers, M.,Leonard, P.,Jarvis, R.E.,Blackaby, W.,Eznarriaga, M.,Lazari, O.,Yates, D.,Rose, M.,Jang, S.W.,Munoz-Sanjuan, I.,Dominguez, C.
Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's Disease.
J.Med.Chem., 64:5018-5036, 2021
Cited by
PubMed Abstract: Our group has recently shown that brain-penetrant ataxia telangiectasia-mutated (ATM) kinase inhibitors may have potential as novel therapeutics for the treatment of Huntington's disease (HD). However, the previously described pyranone-thioxanthenes (e.g., ) failed to afford selectivity over a vacuolar protein sorting 34 (Vps34) kinase, an important kinase involved with autophagy. Given that impaired autophagy has been proposed as a pathogenic mechanism of neurodegenerative diseases such as HD, achieving selectivity over Vps34 became an important objective for our program. Here, we report the successful selectivity optimization of ATM over Vps34 by using X-ray crystal structures of a Vps34-ATM protein chimera where the Vps34 ATP-binding site was mutated to approximate that of an ATM kinase. The morpholino-pyridone and morpholino-pyrimidinone series that resulted as a consequence of this selectivity optimization process have high ATM potency and good oral bioavailability and have lower molecular weight, reduced lipophilicity, higher aqueous solubility, and greater synthetic tractability compared to the pyranone-thioxanthenes.
PubMed: 33783225
DOI: 10.1021/acs.jmedchem.1c00114
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.12 Å)
構造検証レポート
Validation report summary of 6ykg
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon